Abbvie Inc [ABBV] stock prices are down -0.48% to $229.74 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The ABBV shares have gain 0.80% over the last week, with a monthly amount glided 0.90%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Abbvie Inc [NYSE: ABBV] stock has seen the most recent analyst activity on December 10, 2025, when HSBC Securities upgraded its rating to a Buy but kept the price target unchanged to $265 for it. Previously, Scotiabank started tracking the stock with Sector Outperform rating on November 13, 2025, and set its price target to $280. On November 04, 2025, downgrade downgraded it’s rating to Hold but maintained its price target of $237 on the stock. Erste Group downgraded its rating to a Hold. HSBC Securities downgraded its rating to a Hold. Berenberg upgraded its rating to Buy for this stock on September 17, 2025, but kept the price target unchanged to $270.
The stock price of Abbvie Inc [ABBV] has been fluctuating between $164.39 and $244.81 over the past year. Currently, Wall Street analysts expect the stock to reach $260.29 within the next 12 months. Abbvie Inc [NYSE: ABBV] shares were valued at $229.74 at the most recent close of the market. An investor can expect a potential return of 13.3% based on the average ABBV price forecast.
Analyzing the ABBV fundamentals
The Abbvie Inc [NYSE:ABBV] reported sales of 59.64B for trailing twelve months, representing a surge of 9.10%. Gross Profit Margin for this corporation currently stands at 0.76% with Operating Profit Margin at 0.22%, Pretax Profit Margin comes in at 0.03%, and Net Profit Margin reading is 0.04%. To continue investigating profitability, this company’s Return on Assets is posted at 0.02, Equity is 4.99 and Total Capital is 0.14. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -26.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 228.51 points at the first support level, and at 227.27 for the second support level. However, for the 1st resistance point, the stock is sitting at 231.09, and for the 2nd resistance point, it is at 232.44.
Ratios To Look Out For
It’s worth pointing out that Abbvie Inc [NYSE:ABBV]’s Current Ratio is 0.72. Also, the Quick Ratio is 0.60, while the Cash Ratio stands at 0.14. Considering the valuation of this stock, the price to sales ratio is 6.81 and price to earnings (TTM) ratio is 173.35.
Transactions by insiders
Recent insider trading involved Richard A. Gonzalez, Former Director, that happened on Aug 22 ’25 when 62755.0 shares were purchased. Former Director, Richard A. Gonzalez completed a deal on Aug 21 ’25 to buy 90000.0 shares. Meanwhile, EVP, CHIEF OPERATIONS OFFICER SALEKI-GERHARDT AZITA sold 42370.0 shares on Aug 12 ’25.
